Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines

被引:15
|
作者
Sviridonov, Ludmila [1 ]
Dobkin-Bekman, Masha [1 ]
Shterntal, Boris [1 ]
Przedecki, Fiorenza [1 ]
Formishell, Linor [1 ]
Kravchook, Shani [1 ]
Rahamim-Ben Navi, Liat [1 ]
Bar-Lev, Tali Hana [1 ]
Kazanietz, Marcelo G. [2 ]
Yao, Zhong [3 ]
Seger, Rony [3 ]
Naor, Zvi [1 ]
机构
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel
[2] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[3] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
基金
以色列科学基金会; 美国国家科学基金会;
关键词
GnRH; GnRH receptor; Protein kinase C; MAP kinase; Pituitary cells; Prostate cancer cells; PROTEIN-KINASE-C; HORMONE-RELEASING HORMONE; EPIDERMAL-GROWTH-FACTOR; N-TERMINAL KINASE; EGF RECEPTOR; REGULATED KINASE; INDUCED APOPTOSIS; CARCINOMA-CELLS; TYROSINE PHOSPHORYLATION; TRANSDUCTION PATHWAYS;
D O I
10.1016/j.mce.2013.01.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The GnRH receptor (GnRHR) mediates the pituitary functions of GnRH, as well as its anti-proliferative effects in sex hormone-dependent cancer' cells. Here we compare the signaling of GnRHR in pituitary gonadotrope cell lines vs. prostate cancer cell lines. We first noticed that the expression level of PKC alpha, PKC beta II and PKC epsilon is much higher in alpha T3-1 and L beta T2 gonadotrope cell lines vs: LNCaP and DU-145 cell lines, while the opposite is seen for PKC delta. Activation of PKC alpha, PKC beta II and PKC epsilon by GnRH is relatively transient in alpha T3-1 and L beta T2 gonadotrope cell lines and more prolonged in LNCaP and DU-145 cell lines. On the otherhand, the activation and re-distribution of the above PKCs by PMA was similar for both gonadotrope cell lines and prostate cancer cell lines. Activation of ERK1/2 by GnRH and PMA was robust in the gonadotrope cell lines, with a smaller effect observed in the prostate cancer cell lines. The Ca2+ ionophore A23187 stimulated ERK1/2 in gonadotrope cell lines but not in prostate cancer cell lines. GnRH, PMA and A23187 stimulated JNK activity in gonadotrope cell lines, with a more sustained effect in prostate cancer cell lines. Sustained activation of p38 was observed for PMA and A23187 in Du-145 cells, while p38 activation by GnRH, PMA and A23187 in L beta T2 cells was transient. Thus, differential expression and re-distribution of PKCs by GnRH and the transient vs. the more sustained nature of the activation of the PKC-MAPK cascade by GnRH in gonadotrope cell lines vs. prostate cancer cell lines respectively, may provide the mechanistic basis for the cell context-dependent differential biological responses observed in GnRH interaction with pituitary gonadotropes vs. prostate cancer cells. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:107 / 118
页数:12
相关论文
共 50 条
  • [1] Plasma membrane expression of GnRH receptors: regulation by antagonists in breast, prostate, and gonadotrope cell lines
    Finch, Ann R.
    Sedgley, Kathleen R.
    Caunt, Christopher I.
    McArdle, Craig A.
    JOURNAL OF ENDOCRINOLOGY, 2008, 196 (02) : 353 - 367
  • [2] Cytogenetic, Genomic, and Functional Characterization of Pituitary Gonadotrope Cell Lines
    Ruf-Zamojski, Frederique
    Ge, Yongchao
    Pincas, Hanna
    Shan, Jidong
    Song, Yinghui
    Hines, Nika
    Kelley, Kevin
    Montagna, Cristina
    Nair, Pranav
    Toufaily, Chirine
    Bernard, Daniel J.
    Mellon, Pamela L.
    Nair, Venugopalan
    Turgeon, Judith L.
    Sealfon, Stuart C.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (05): : 902 - 920
  • [3] The role of BRCA1 in androgen receptor signaling in prostate cancer cell lines
    Clark, PE
    Irvine, RA
    Park, JJ
    Press, MF
    Coetzee, GA
    JOURNAL OF UROLOGY, 2002, 167 (04): : 52 - 53
  • [4] Bone morphogenetic protein signaling in prostate cancer cell lines
    Brubaker, KD
    Corey, E
    Brown, LG
    Vessella, RL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (01) : 151 - 160
  • [5] GnRH-PAP hormonotoxin targets cytotoxicity to prostate cancer cell lines
    Lin Qi
    Terry M. Nett
    Matthew C. Allen
    Xiaoming Sha
    Gail S. Harrison
    Barbara A. Frederick
    L. Michael Glode
    Urological Research, 2003, 31 : 374 - 377
  • [6] Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines
    Marques, Rute B.
    Dits, Natasja F.
    Erkens-Schulze, Sigrun
    van Ijcken, Wilfred F. J.
    van Weerden, Wytske M.
    Jenster, Guido
    PLOS ONE, 2011, 6 (08):
  • [7] Defects in Muscarinic Receptor Cell Signaling in Bladder Urothelial Cancer Cell Lines
    Tully, Brian T.
    Li, Mingkai
    Sun, Yan
    Berkowitz, Jared
    Chai, Toby C.
    UROLOGY, 2009, 74 (02) : 467 - 473
  • [8] Leptin Signaling and Apoptotic Effects in Human Prostate Cancer Cell Lines
    Samuel-Mendelsohn, Sigal
    Inbar, Michal
    Weiss-Messer, Esther
    Niv-Spector, Leonora
    Gertler, Arieh
    Barkey, Ronnie J.
    PROSTATE, 2011, 71 (09): : 929 - 945
  • [9] Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines
    Guo, CH
    Luttrell, LM
    Price, DT
    JOURNAL OF UROLOGY, 2000, 163 (03): : 1027 - 1032
  • [10] Bone morphogenetic protein signaling in prostate cancer cell lines.
    Brubaker, KD
    Vessella, RL
    Brown, LG
    Corey, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S200 - S200